The long-term pathological evolution of chronic hepatitis C

被引:458
作者
Yano, M
Kumada, H
Kage, M
Ikeda, K
Shimamatsu, K
Inoue, O
Hashimoto, E
Lefkowitch, JH
Ludwig, J
Okuda, K
机构
[1] CHIBA UNIV, SCH MED, DEPT MED 1, CHUO KU, CHIBA 260, JAPAN
[2] NAGASAKI CHUO NATL HOSP, INST CLIN RES, OHMURA, JAPAN
[3] TORANOMON GEN HOSP, DEPT GASTROENTEROL, TOKYO, JAPAN
[4] KURUME UNIV, SCH MED, DEPT PATHOL 1, KURUME, FUKUOKA, JAPAN
[5] TOKYO WOMENS MED COLL, INST GASTROENTEROL, TOKYO 162, JAPAN
[6] COLUMBIA UNIV, COLL PHYS & SURG, NEW YORK, NY USA
[7] MAYO CLIN, DEPT MED PATHOL, ROCHESTER, MN USA
[8] CHIBA UNIV, SCH MED, CHIBA 280, JAPAN
关键词
D O I
10.1053/jhep.1996.v23.pm0008675148
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Most patients infected with hepatitis C virus (HCV) develop chronic hepatitis. Unfortunately, the pathological evolution of this disease over time is not completely understood. We studied 70 HCV-positive patients, from whom 2 to 10 liver biopsy specimens (mean, 3.9) had been obtained during an interval of 1 to 26 years (mean, 8.8 years). Each biopsy specimen was evaluated-independently by four pathologists who each provided a numerical score for the grade of portal/periportal necroinflammation (0-4), grade of lobular necroinflammation (0-4), their sum (final grade), and the stage of fibrosis (1-4), The scores were correlated with progression of disease, if any, and transition to cirrhosis. During follow-up, 35 patients (50%) developed cirrhosis. Cirrhosis developed in all patients with a high final grade (greater than or equal to 5) of necroinflammation on initial biopsy who were followed for 10 years and in 96% of patients with an intermediate final grade (3.5-4.9) who were followed for 17 years. Only 30.4% of patients with low final grade (less than or equal to 3.4) on initial biopsy developed cirrhosis after 13 years. All patients with evidence of septal fibrosis with incomplete nodularity (stage 3.0-3.4) in the initial biopsy progressed to unequivocal cirrhosis by 10 years. The rate of progression to cirrhosis was accelerated in patients whose initial biopsies showed high-grade and -stage lesions, This study demonstrates the importance of grading and staging liver biopsy lesions in chronic hepatitis C, particularly for patients with high-grade necroinflammation, septal fibrosis, and regions of nodularity on initial biopsy who are at high risk of developing advanced cirrhosis in the ensuing decade.
引用
收藏
页码:1334 / 1340
页数:7
相关论文
共 50 条
  • [21] LONG-TERM THERAPY OF CHRONIC HEPATITIS AND OF HEPATOCIRRHOSIS
    PUSCH, HJ
    ULLMANN, W
    MEDIZINISCHE KLINIK, 1975, 70 (15) : 674 - 681
  • [22] The long-term course of chronic hepatitis B
    Di Marco, V
    Lo Iacono, O
    Cammà, C
    Vaccaro, A
    Giunta, M
    Martorana, G
    Fuschi, P
    Almasio, PL
    Craxì, A
    HEPATOLOGY, 1999, 30 (01) : 257 - 264
  • [23] Long-term evolution of serum and liver viral markers in patients treated for chronic hepatitis C and sustained response
    Moreno, M
    Pérez-Alvarez, R
    Rodrigo, L
    Pérez-López, R
    Suárez-Leiva, P
    JOURNAL OF VIRAL HEPATITIS, 2006, 13 (01) : 28 - 33
  • [24] LONG-TERM FOLLOW-UP OF PATIENTS WITH HEPATITIS-C VIRUS CHRONIC HEPATITIS
    VELASCO, M
    BRAHM, J
    KATZ, R
    REVISTA MEDICA DE CHILE, 1994, 122 (11) : 1271 - 1275
  • [25] Long-term effects of interferon-based therapy for chronic hepatitis C
    Yu, Ming-Lung
    Huang, Chung-Feng
    Dai, Chia-Yen
    Huang, Jee-Fu
    Chuang, Wan-Long
    ONCOLOGY, 2007, 72 : 16 - 23
  • [26] LONG-TERM PERSISTENCE OF IGM ANTIBODIES TO HCV IN CHRONIC HEPATITIS-C
    BRILLANTI, S
    FOLI, M
    PERINI, P
    MASCI, C
    MIGLIOLI, M
    BARBARA, L
    JOURNAL OF HEPATOLOGY, 1993, 19 (01) : 185 - 187
  • [27] Long-term outcome of chronic hepatitis C virus infection in primary hypogammaglobulinaemia
    Bjoro, K
    Skaug, K
    Haaland, T
    Froland, SS
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 1999, 92 (08) : 433 - 441
  • [28] Efficacy prediction and long-term relapse in the management of treatment of chronic hepatitis C
    Wang, Xiaohong
    Li, Quanrun
    Zhang, Changjiang
    Xiong, Yulin
    Zhu, Yan
    HEPATOLOGY, 2012, 56 : 1053A - 1053A
  • [29] Influence of the long-term persistence of HGV on the natural course of chronic hepatitis C
    Wiese, M
    Hohne, M
    Schreier, E
    GUT, 1997, 41 : A83 - A83
  • [30] LONG-TERM THERAPEUTIC EFFICACY OF INTERFERON FOR PATIENTS WITH CHRONIC HEPATITIS-C
    TAKEDA, T
    KUROKI, T
    FUKUDA, K
    YABUSAKO, T
    NISHIGUCHI, S
    NAKAJIMA, S
    SHIOMI, S
    SEKI, S
    MONNA, T
    SAKURAI, M
    KOBAYASHI, K
    GASTROENTEROLOGIA JAPONICA, 1993, 28 : 104 - 108